Gens & Associates launches latest World Class RIM℠ study - the largest yet - to define & hone "industry standard" practice
NEWTOWN, Pa., Oct. 4, 2023 /PRNewswire-PRWeb/ -- Leading Life Science benchmarking and advisory firm Gens & Associates has launched its largest World Class RIM℠ Benchmark study to date. The 2024 global study of Life Sciences regulatory information management programs – the 6th in the firm's World-Class RIM series (which dates back to 2015) – will be the farthest reaching and most inclusive in terms of respondents. It will also be the deepest dive yet into hot topics such as structured data submission programs, advanced technology application to key regulatory processes, and regulatory digitization strategies.
- NEWTOWN, Pa., Oct. 4, 2023 /PRNewswire-PRWeb/ -- Leading Life Science benchmarking and advisory firm Gens & Associates has launched its largest World Class RIM℠ Benchmark study to date.
- Over the last five years, Life Sciences companies across the world have collectively spent over $1.9 billion on improving regulatory information management, Gens & Associates estimates.
- The latest study will explore the impact of that investment, for instance in tangibly transforming organizations' regulatory intelligence and cross-function process efficiency.
- The 2024 World Class RIM Benchmark study is Gens & Associates' 43rd comprehensive research project in 17 years.